Legacy Pharma Research is categorized under Business Management Consultants in Bismarck, ND and active since 2008.
Legacy Pharma Research was established in 2008, and today employs 1 to 4, earning Unknown per year. This is a Business Management Consultants business, which does work in the B2B market, and is classified as a Business Management Consultants, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Diane Davis, Owner at the company’s single location by writing to 601 North 5th St, Bismarck, North Dakota ND 58501 or by phoning (701) 751-1128. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Legacy Pharma Research |
Contact Person: | Diane Davis, Owner |
Address: | 601 North 5th St, Bismarck, North Dakota 58501 |
Phone Number: | (701) 751-1128 |
Website Address: | legacypharmaresearch.com |
Annual Revenue (USD): | Unknown |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Management Consultants |
SIC Code: | 8742 |
NAICS Code: | 5417115 |
Share This Business: |
Legacy Pharma Research was started in 2008 to provide professional Business Management Consultants under the SIC code 8742 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Diane Davis, Owner for inquiries that concern Legacy Pharma Research by calling the company number (701) 751-1128, as your correspondence is most welcome. Additionally, the physical location of the single location of Legacy Pharma Research can be found at the coordinates 46.8108,-100.78441 as well as the street address 601 North 5th St in Bismarck, North Dakota 58501.
For its online presence, you may visit Legacy Pharma Research’s website at legacypharmaresearch.com and engage with its social media outlets through on Twitter and on Facebook.